Chris Bosh almost died in January, and the first thing he wants Victor Wembanyama to internalize is a four-word sentence that sounds like a scolding parent until you map it against the body count. Take your medicine. That is not locker-room chatter. That is a Hall of Famer describing the difference between a living room and a hospital bed.
Bosh sat down with HoopsHype at a charity 3×3 event and did not soften the edges. “Yeah, I had an episode in January. I almost dropped dead pretty much and came back to life. I’m not joking.” Another pulmonary embolism. A week in the hospital. No warning symptoms. The same condition that already stole the back half of his prime. He thought he was clear of it. He is not. “You got to deal with it for the rest of your life.”
I keep replaying that line against what Wembanyama just did. Cleared in July 2025 after the deep vein thrombosis in his right shoulder shut him down at 46 games in 2024-25. Then 64 games the following season, all the way into a five-game NBA Finals against the Knicks. The Spurs managed the minutes and the monitoring. The Frenchman talked about the diagnosis like a trauma he flipped into fuel. “When I first learned the news, I broke down,” he told Love Magazine. “For a while, I allowed myself to feel totally vulnerable and defenseless. But then I pivoted my mind and started looking at it as a challenge.”
That pivot is real. It is also incomplete.
The Second Clot Is the Career Killer
Bosh’s own tape is the warning label. First clot in February 2015: leg to lung, multi-day hospitalization, rest of that season gone. He came back and logged 53 games in 2015-16. Then February 2016 delivered the second clot. Doctors shut him down. The league eventually classified it career-ending. Thirteen years, 11 All-Star nods, and the ending was not a torn Achilles or a lost step. It was blood that refused to stay thin enough for contact.
“It happened one more time for me, it happened twice, and I couldn’t play anymore,” Bosh said. That is the mechanism. One recurrence ends the negotiation with the medical staff. Blood thinners keep you alive; they also make every screen, every dive on a loose ball, every mid-air collision a different risk equation. The Spurs and Wembanyama’s circle know this. They built the apparatus around him: trainers, therapists, doctors, surgeons. Bosh is still telling them the apparatus only works if the patient never gets casual.
I am not interested in the fairy-tale version where generational talent overrides biology. Wembanyama is 7-foot-3 with a frame that already asks more of the circulatory system than a normal body. He was 21 when the DVT hit. The return looked clean. Clean is not cured. Bosh thought he was past it too.
Compliance Is the Real Minutes Restriction
The basketball world will talk about load management and defensive schemes and whether the Spurs can surround him with enough shooting. Fine. Those are secondary variables. The primary one is whether a 22-year-old superstar treats daily anticoagulation and monitoring with the same non-negotiable seriousness he treats a pre-game shooting routine. Bosh’s language is blunt on purpose: “Make sure that he’s staying on top of his regimen to make sure that doesn’t happen again because it only takes one more time… just making sure he does everything necessary to keep that blood as thin as possible and take care of that body off the court.”
Off the court. That is the tell. The games are the easy part once you are cleared. The boring, invisible adherence is what decides if there is a third contract, a second Finals run, a decade of dominance instead of a Hall of Fame speech that starts with “what if.”
I watched Bosh’s Heat teams. The length, the switching, the way he stretched floors before it was mandatory. His career did not end because the talent evaporated. It ended because the second clotting event removed the option of continuing. Wembanyama’s 64-game grind and Finals appearance prove the Spurs’ medical group did excellent work the first time. They do not prove the risk retired.
Bosh is not speaking as a retired star burnishing relevance. He is speaking as someone who flatlined the odds in January and woke up still tethered to a daily pill. The edge in his voice is earned. Wembanyama has the physical tools to warp the league for fifteen years. He also has a condition that reduced one of the best bigs of his generation to a cautionary press conference. The only variable that closes that gap is relentless, unsexy compliance.
Take the medicine. Every day. No days off for feeling healthy. Bosh already ran the experiment. The second failure was terminal to the career. Wembanyama does not get to skip the data just because the first comeback looked like a movie.
